Dexetimide: an effective drug for the control of extrapyramidal symptoms induced by pipothiazine palmitate.
D000284:Administration, Oral; D000328:Adult; D000978:Antiparkinson Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001480:Basal Ganglia Diseases / Q000139:chemically induced / Q000175:diagnosis / Q000188:drug therapy* / Q000517:prevention & control; D001593:Benzyl Compounds / Q000008:administration & dosage / Q000627:therapeutic use; D003692:Delayed-Action Preparations; D004341:Drug Evaluation; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D008875:Middle Aged; D010169:Palmitic Acids / Q000009:adverse effects / Q000627:therapeutic use; D010640:Phenothiazines; D010880:Piperidines / Q000009:adverse effects / Q000627:therapeutic use*; D010881:Piperidones / Q000008:administration & dosage / Q000627:therapeutic use; D010919:Placebos; D011618:Psychotic Disorders / Q000188:drug therapy; D012075:Remission, Spontaneous; D013449:Sulfonamides / Q000009:adverse effects / Q000627:therapeutic use
D000978:Antiparkinson Agents; D014150:Antipsychotic Agents; D001593:Benzyl Compounds; D003692:Delayed-Action Preparations; D010169:Palmitic Acids; D010640:Phenothiazines; D010880:Piperidines; D010881:Piperidones; D010919:Placebos; D013449:Sulfonamides